Finance

Lists
Why is AAPG down ९.०३%?
Dive Deeper
AAPG:NASDAQ
Ascentage Pharma Group Internatinl - ADR
US$ १३.३०
-९.०३%
(-१.३२) 1D
नोभेम्बर १६, १६:००:०० GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AAPG...
Open
US$ १३.६३
High
US$ १३.९०
Low
US$ १३.२५
Mkt. cap
१.२२ अरब
Avg. vol.
७.७४ हजार
Volume
०.००
52-wk high
US$ ३२.९६
52-wk low
US$ १३.२५
EPS
-US$ २.३७
Shares outstanding
९.३७ करोड
No. of employees
८२८
Open
US$ १३.६३
High
US$ १३.९०
Low
US$ १३.२५
Mkt. cap
१.२२ अरब
Avg. vol.
७.७४ हजार
Volume
०.००
52-wk high
US$ ३२.९६
52-wk low
US$ १३.२५
EPS
-US$ २.३७
Shares outstanding
९.३७ करोड
No. of employees
८२८
News stories
From web sources and news partners
The Motley Fool
The Motley Fool
·
५३ मिनेट पहिले
Could the Vanguard S&P 500 ETF Set You Up for Life? Here's What History Says.
The Motley Fool
The Motley Fool
·
१ घण्टा पहिले
The S&P 500 Had Its Worst Day in Over a Year. Here's Why I'm Still Investing.
TradingView
TradingView
·
३ घण्टा पहिले
Stock Market: Will S&P 500 Open Up or Down Today?
Trefis
Trefis
·
१ घण्टा पहिले
31 S&P 500 Stocks Just Made New 52-Week Highs
About Ascentage Pharma Group Internatinl - ADR
CEODajun Yang
Employees८२८
Founded२००९
Headquarters-
SectorHealth Care
Industry-
Analyst ratings
Based on 7 analysts giving stock ratings to AAPG in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for AAPG in the last 3 months.
Highest
Current US$ १३.३०
US$ ४८.०० (+२६०.९०%)
Average
US$ ४२.०० (+२१५.७९%)
Lowest
US$ ३३.०० (+१४८.१२%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jeet Mukherjee
BTIG
Buy
Maintained
US$ ४८.००
+२६०.९%
11/05/2026
Yigal Nochomovitz
Citi
Buy
Initiated
US$ ४६.००
+२४५.९%
10/15/2026
Silvan Turkcan
Citizens JMP
Buy
Initiated
US$ ३५.००
+१६३.२%
10/13/2026
Brian Cheng
J.P. Morgan
Buy
Maintained
US$ ३३.००
+१४८.१%
10/08/2026
Mayank Mamtani
B. Riley Securities
Buy
Maintained
US$ ४५.००
+२३८.३%
09/02/2026
Gregory Renza
Truist Financial
Buy
Maintained
-
-
08/21/2026
Jeff Jones
Oppenheimer
Buy
Maintained
US$ ४५.००
+२३८.३%
08/21/2026
Biren Amin
Piper Sandler
Buy
Maintained
US$ ४८.००
+२६०.९%
06/01/2026
James Shin
Deutsche Bank
Buy
Initiated
US$ ४०.००
+२००.८%
04/24/2026
Matthew Biegler
Oppenheimer
Buy
Reiterated
US$ ४५.००
+२३८.३%
03/27/2026
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१७.०२ करोड
१७.०२ करोड
१५.११ करोड
१५.११ करोड
Cost of goods sold
१.३६ करोड
१.३६ करोड
५८.६२ लाख
५८.६२ लाख
Cost of revenue
१.३६ करोड
१.३६ करोड
५८.६२ लाख
५८.६२ लाख
Research and development expenses
३०.४४ करोड
३०.४४ करोड
३४.८७ करोड
३४.८७ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१८.१२ करोड
१८.१२ करोड
१७.२६ करोड
१७.२६ करोड
Operating expense
४८.५७ करोड
४८.५७ करोड
५२.१४ करोड
५२.१४ करोड
Total operating expenses
४९.९३ करोड
४९.९३ करोड
५२.७२ करोड
५२.७२ करोड
Operating income
-३२.९१ करोड
-३२.९१ करोड
-३७.६१ करोड
-३७.६१ करोड
Other non operating income
-२९.८८ लाख
-२९.८८ लाख
-३.०१ करोड
-३.०१ करोड
EBT including unusual items
-३२.५४ करोड
-३२.५४ करोड
-४०.१७ करोड
-४०.१७ करोड
EBT excluding unusual items
-३२.४८ करोड
-३२.४८ करोड
-४०.१७ करोड
-४०.१७ करोड
Income tax expense
७.१४ लाख
७.१४ लाख
६८.१२ लाख
६८.१२ लाख
Effective tax rate
-०.२२%
-०.२२%
-१.७०%
-१.७०%
Other operating expenses
-
-
-
-
Net income
-३२.६० करोड
-३२.६० करोड
-४०.८३ करोड
-४०.८३ करोड
Net profit margin
-१९१.५३%
-१९१.५३%
-२७०.२४%
-२७०.२४%
Earnings per share
-
-
-
-
Interest and investment income
२.५४ करोड
२.५४ करोड
१.८० करोड
१.८० करोड
Interest expense
-१.३१ करोड
-१.३१ करोड
-१.३४ करोड
-१.३४ करोड
Net interest expenses
१.२२ करोड
१.२२ करोड
४५.८८ लाख
४५.८८ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-३१.१० करोड
-३१.१० करोड
-३५.७० करोड
-३५.७० करोड
Gain or loss from assets sale
-३.३४ लाख
-३.३४ लाख
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू